Other than some shiny, happy talk about the sub-lingual grass allergy candidate Phase III results (which are good — just not likely to be material, near term), I don’t expect much new or noteworthy tomorrow, at the Credit Suisse Healthcare Conference with Mr. Kellogg, at the mic. But I’ll tune in, mid afternoon, Mountain time, just the same — to be sure.
Here is the announcement:
. . . .Merck known as MSD outside the United States and Canada, announced today that Peter N. Kellogg, executive vice president and chief financial officer, Merck, is scheduled to present at the Credit Suisse Healthcare Conference, Scottsdale, Arizona on Tuesday, Nov. 12, 2013 at 3:30 pm [MST]. Investors, analysts, members of the media and the general public are invited to join a live webcast of the presentation. . . .
We will relay anything material and new, should any such matter be discussed. Trust that. [As I reflect on it a moment, though I suppose he might lay to rest some of the rumors about Animal Health’s future.]